Related Experiment Video
Updated: Jul 19, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children
S Sri Ranganathan1, M G Sathiadas, S Sumanasena
1Department of Pharmacology, Faculty of Medicine, University of Colombo, Sri Lanka.
Insights
Overusing paracetamol (acetaminophen) with therapeutic intent in children with fever increases the risk of developing fulminant hepatic failure. This overuse leads to significantly higher paracetamol levels and severe liver injury.
Area of Science:
- Pediatric Hepatology
- Clinical Pharmacology
- Toxicology
Background:
- Fulminant hepatic failure (FHF) is a rare but severe complication in children.
- Paracetamol (acetaminophen) is a common antipyretic used in febrile children.
- Understanding risk factors for FHF is crucial for patient safety.
Purpose of the Study:
- To investigate the association between paracetamol overuse and FHF in children treated for febrile illnesses.
- To quantify paracetamol exposure in children who developed FHF.
Main Methods:
- A case-control study comparing 25 children with FHF to 33 age-matched controls.
- Assessed paracetamol ingestion history and measured serum paracetamol levels.
- Evaluated clinical presentation including hepatic encephalopathy grading and liver enzyme levels.
Main Results:
- All FHF cases consumed supra-therapeutic paracetamol doses (mean 145 mg/kg/day), unlike controls.
- Mean serum paracetamol levels were significantly higher in cases (26.84 mg/dL) vs. controls (0.051 mg/dL).
- FHF cases showed higher rates of hepatomegaly, jaundice, and elevated alanine aminotransferase (ALT).
Conclusions:
- Supra-therapeutic paracetamol dosing is a significant risk factor for FHF in febrile children.
- This risk is associated with acute viral-like febrile illnesses.
- Careful monitoring of paracetamol dosage is essential in pediatric fever management.
Objective:
To evaluate the risk of fulminant hepatic failure in relation to paracetamol overuse with therapeutic intent in febrile children.
Methods:
It was a case control study. Paracetamol ingestion for the current febrile illness was compared between 25 cases of fulminant hepatic failure and 33 hospital age matched controls.
Results:
Supra-therapeutic doses of paracetamol (mean 145 mg/kg/day) were consumed by all 25 cases compared to none in the control group. Mean paracetamol level in the cases and controls were, respectively, 26.84 mg /dl and 0.051 mg /dl (p< 0.001). The mean duration of paracetamol intake prior to admission in cases was 3. 45 days compared to 1.85 days in the control group. Nineteen, 5 and 3 were, respectively, graded as hepatic encephalopathy grade 1, 2 and 3. All six patients in grade 2 and 3 had hepatomegaly compared to 78% in the grade 1. Four had jaundice and all were in grade 2 or 3. Mean alanine aminotransferase was 2781 U/L None of the randomly selected cases (6) had serological evidence of Hepatitis A, Hepatitis B or Dengue. Three cases died.
Conclusion:
Exposure to multiple supratherapeutic doses of paracetamol is a risk factor to develop fulminant hepatic failure in children with an acute viral like febrile illness.
Related Concept Videos
Increased Body Temperature
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Hepatic Encephalopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmaceutical Poisoning: Potential Scenarios
